Citation Information :
Rajput A, Kumar U, Sinha N, Kumar G, Vashisht R, Gauba K, Kanase A. Emergency Pain Management of Untreated Pulpitis during COVID-19 Lockdown by Telephonic Communication. World J Dent 2022; 13 (4):358-361.
To evaluate the beneficial effects of orally administered corticosteroids in alleviating the pain of symptomatic pulpitis.
Materials and Methods: Out of the 87 patients who contacted the expert panel telephonically during the period of COVID-19 lockdown, 55 patients complaining of moderate to severe dental pain were included in the study and thus advised to take oral tablets of paracetamol 650 mg postmeal thrice a day for 3–5 days along with a single oral dose of 4 mg of dexamethasone. The patients were asked to report their pain status after every 24 hours for at least 72 hours. In case of severe pain not controlled by these medicines even after 3 days, two tablets of dispersible ketorolac tromethamine (10 mg) were advised once on the fourth day, followed by a single tablet three times a day for another 3 days. In case the pain did not subside within 3 days of taking the second line of treatment, or there was a development of swelling/lymphadenopathy, the patient was advised to get the tooth extracted.
Results: Out of 55 patients taking a single dose of dexamethasone, 47 (85.45%) patients reported a “significant” reduction of pain within 24–72 hours. The remaining eight patients (14.55%) in which severe pain was not controlled by paracetamol and dexamethasone even after 3 days, two tablets of ketorolac tromethamine (10 mg) were advised. Six patients (75%) reported a “significant” reduction in the pain, while two (25%) patients still in pain were advised tooth extraction and were referred to the emergency department of the tertiary care center.
Conclusion: For the pain felt by patients diagnosed with symptomatic irreversible pulpitis, systemic corticosteroids administration is an adequate strategy in controlling pain for up to 48–72 hours, the time during which the pain is felt most.
Our World in Data. Total and daily confirmed COVID-19 cases, 2020. https://ourworldindata.org/grapher/total-and-dailycases-covid-19?
Meng LY, Hua F, Bian Z. Coronavirus disease 2019 (COVID-19): emerging and future challenges for dental and oral medicine. J Dent Res 2020;99(5):481-487. DOI: 10.1177/0022034520914246
Smales FC, Samaranyake LP. Maintaining dental education and specialist dental care during an outbreak of a new coronavirus infection. Part 1: a deadly viral epidemic begins. Br Dent J 2003;195(10):557–561. DOI: 10.1038/sj.bdj.4810723
Liesinger A, Marshall FJ, Marshall JG. Effect of variable doses of dexamethasone on post treatment endodontic pain. J Endod 1993;19(1):35–39. DOI: 10.1016/S0099-2399(06)81039-3
Gallatin E, Isett J, Reader A, et al. Effect of an intraosseous injection of depo-medrol on pulpal concentrations of PGE2 and IL-8 in untreated irreversible pulpitis. J Endod 2003;29(4):268–271. DOI: 10.1097/00004770-200304000-00010
Hasselgren G, Reit C. Emergency pulpotomy: pain relieving effect with and without the use of sedative dressings. J Endod 1989;15(6):254–256. DOI: 10.1016/S0099-2399(89)80219-5
Taha NA, Khazali MA. Partial pulpotomy in mature permanent teeth with clinical signs indicative of irreversible pulpitis: a randomized clinical trial. J Endod 2017;43(9):1417–1421. DOI: 10.1016/j.joen.2017.03.033
Hargreaves KM, Seltzer S. Pharmacologic control of dental pain. In: Hargreaves KM, Goodis H, eds. Seltzer and Bender's dental pulp. Chicago: Quintessence Publications, 2002. ISBN: 978-0-86715-480-1, 9780867154801.
Hargeaves K, Abott PV. Drug for pain management in dentistry. Aust Dent J 2005;50(4 Suppl 2):S14–22. DOI: 10.1111/j.1834-7819.2005.tb00378.x
Smith EA, Marshal JG, Selph SS, et al. Nonsteroidal anti-inflammatory drugs for managing postoperative endodontic pain in patients who present with preoperative pain: a systematic review and meta-analysis. J Endod 2017;43(1):7–15. DOI: 10.1016/j.joen.2016.09.010
Genet JM, Hart AAM, Wesselink PR, et al. Preoperative and operative factors associated with pain after the first endodontic visit. Int Endod J 1987;20(2):53–64. DOI: 10.1111/j.1365-2591.1987.tb00590.x
Mohammadi Z. Systemic and local applications of steroids in endodontics: an update review. Int Dent J 2009;59(5):297–304. DOI: 10.1922/IDJ_2071Mohammadi08
Nogueira BML, Silva LG, Mesquita CRM, et al. Is the ue of dexamethasone effective in controlling pain associated with symptomatic irreversible pulpitis? a systematic review. J Endod 2018;44(5):703–710. DOI: 10.1016/j.joen.2018.02.006
Suneelkumar C, Subha A, Gogala D. Effect of pre operative corticosteroids in patients with symptomatic pulpitis on post operative pain after single visit root canal treatment: a systematic review and meta analysis. J Endod 2018;44:1347–1354. DOI:10.1016/j.joen.2018.05.015
Stewart G. The antihistamines and corticosteroids in the reduction of postoperative sequelae following endodontic surgery. Endodontics 1956;9(2):216–220. DOI:10.1016/0030-4220(56)90102-5
Bramy E, Reader A, Beck M, et al. The intraosseous injection of Depo-medrol on postoperative endodontic pain in symptomatic, necrotic teeth. J Endod 1999;25:289 (Abstract OR 29). DOI: 10.1016/S0099-2399(99)80189-7
Hargeaves KM, Costello A. Glucocorticoids suppress levels of immunoreactive bradykinin in inflamed tissue as evaluated by microdialysis probes. Clin Pharmacol Ther 1990;48(2):168–178. DOI: 10.1038/clpt.1990.132
Glassman G, Krasner P, Morse DR, et al. A prospective randomized double-blind trial on efficacy of dexamethasone for endodontic interappointment pain in teeth with asymptomatic inflamed pulps. Oral Surg Oral Med Oral Pathol 1989;67(1):96–100. DOI: 10.1016/0030-4220(89)90310-1